Tag: astrazeneca

All

AstraZeneca Monoclonal Antibody Effective as Preventative Therapy

AZD7442, a monoclonal antibody cocktail against the COVID-19 virus, reduced the risk of symptoms in a study of immunocompromised and chronically ill adults later exposed to the virus by 77%, according to AstraZeneca.

Mixing AstraZeneca, Pfizer Jabs Offers Protection, Study Finds
Long-term Data Shows Safety, Effectiveness of Fasenra for Severe Eosinophilic Asthma
AstraZeneca Vax 76% Effective Overall, 100% Prevention of Severe Disease
Safety Board Expresses ‘Concern’ Over AstraZeneca Vaccine Data
AstraZeneca COVID-19 Vaccine 79% Effective in Adults
EU Authorizes AstraZeneca COVID-19 Vaccine
FDA Approves Tagrisso for NSC Lung Cancer

All

AstraZeneca Halts Phase 3 Study of COVID-19 Vaccine after Illness

"A potentially unexplained illness" in a recipient of AstraZeneca's COVID-19 vaccine candidate AZD1222 has halted the company's phase 3 clinical trial, the AP reports.